DEPLOYThe reference layer for physical AI

Deployment

Oura Ring 4 at Global

Oura (Oura Health, founded 2013 in Oulu, Finland) makes the Oura Ring, a biometric-primary titanium smart ring with sleep and readiness AI, recorded in the new biometric form factor, with the Oura Ring 4 from late 2024 introducing its Smart Sensing platform that expanded signal pathways from eight to eighteen on roughly an eight-day battery. It pairs heart-rate and heart-rate-variability, blood-oxygen-trend, multi-point temperature, and accelerometer sensing with sleep staging and a Sleep Score, a Readiness Score, activity, stress, cycle tracking with Natural Cycles integration, a VO2 Max estimate, and an AI Oura Advisor across more than 50 metrics, sold by purchase plus a required membership of $5.99 a month. On FDA status, the Oura Ring 4 itself has no clearance and is marketed as a general-wellness product, with its only cleared-feature route via partner integrations such as the FDA-cleared Natural Cycles birth-control app consuming Oura temperature data, where the clearance belongs to the partner. Oura is the disciplined counter-case to Whoop in the verified-versus-claimed framework: it launched a Blood Pressure Profile Study in December 2025 to pursue a hypertension feature, but that feature is investigational and not cleared, so Oura is running the clearance path before marketing blood pressure, in contrast to Whoop's market-first posture that drew an FDA warning letter. A valuation correction is worth recording: Oura is valued at $11 billion after a roughly $900 million Series E in October 2025 led by Fidelity with revenue reportedly above $1 billion in 2025, not the stale roughly $5 billion figure. Its clinical-validation posture is the strongest and growing in the cohort specifically on sleep, with a 2025 Brigham and Women's Hospital study finding it the most accurate consumer sleep tracker for four-stage classification against polysomnography, while its posture is validated wellness rather than a cleared medical device except via partners, and its blood-pressure feature and the accuracy of its Readiness and VO2 Max metrics are investigational or not clearance-validated.

Oura Ring 4 by Oura · Catalog entry · 1 source · not yet field-verified


Machine-readable surfaces

Aggregate global deployment. Oura Ring 4 operations.

Trust tier
Catalog entry · 1 source · not yet field-verified
Last updated
2026-06-08
Model
Oura Ring 4
Company
Oura
Location
Global
Status
operational
ID
5e0a60b6-9270-4519-a1f8-b0ea07609d76

Sources (1)

  1. https://rover.report
Methodology: Verified · 1 source (no primary) · last reviewed 2026-06-08

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-06-08

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: biometric

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Oura Ring 4 at Global.

Common questions

What is the Oura Ring 4 deployment at Global?
Oura Ring 4, built by Oura, is recorded as a deployment at Global on the DEPLOY registry. Oura operates the deployment directly.
Who operates Oura Ring 4 at Global?
Oura, the manufacturer of Oura Ring 4, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
Have there been incidents at the Oura Ring 4 deployment at Global?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.